Evidence supporting the use of: Vitamin E (delta-tocotrienol)
For the health condition: Radiation Sickness

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Delta-tocotrienol, a member of the Vitamin E family, has been investigated for its potential radioprotective effects, primarily in preclinical studies. Scientific interest centers on the antioxidant properties of tocotrienols, which are believed to mitigate radiation-induced oxidative damage to cells and tissues. Several animal studies have demonstrated that delta-tocotrienol can increase survival rates and reduce damage to the hematopoietic system (bone marrow) after exposure to ionizing radiation. These effects are attributed to its ability to scavenge free radicals and modulate signaling pathways involved in inflammation and apoptosis.

Notably, delta-tocotrienol has outperformed other tocotrienol isoforms and tocopherols in some animal models of radiation injury. The U.S. Armed Forces Radiobiology Research Institute has identified delta-tocotrienol as a promising candidate for further development as a radiation countermeasure, and it has progressed through early-stage clinical trials for safety. However, as of mid-2024, robust evidence in humans is lacking. There are no completed large-scale clinical trials confirming efficacy in preventing or treating acute radiation syndrome in humans, and delta-tocotrienol is not approved by regulatory agencies for this indication. Its use for radiation sickness is thus supported by a growing body of animal research and mechanistic rationale, but clinical validation remains incomplete.

More about Vitamin E (delta-tocotrienol)
More about Radiation Sickness

Products containing Vitamin E (delta-tocotrienol)

We currently have no products on Vitabase that contain this ingredient.